CREBH alleviates mitochondrial oxidative stress through SIRT3 mediating deacetylation of MnSOD and suppression of Nlrp3 inflammasome in NASH.
CREBH alleviates mitochondrial oxidative stress through SIRT3 mediating deacetylation of MnSOD and suppression of Nlrp3 inflammasome in NASH.
复制标题
CREBH 通过 SIRT3 介导 MnSOD 脱乙酰化和抑制 NASH 中的 Nlrp3 炎症小体来减轻线粒体氧化应激。
DOI:
10.1016/j.freeradbiomed.2022.07.018
复制
发表时间:
2022-08
期刊:
影响因子:
--
通讯作者:
Xu Keshu
中科院分区:
文献类型:
--
作者:
Zhang Junli;Zhao Yajuan;Wang Shuhan;Li Guixin;Xu Keshu
Lipotoxicity and unresolved oxidative stress are key drivers of metabolic inflammation in nonalcoholic steatohepatitis (NASH). cAMP-response element binding protein H(CREBH) is a liver-specific transcription factor and regulates the glucose and lipid metabolism of NASH. However, its role in mitochondrial oxidative stress and its association with sirtuin 3 (SIRT3), a master regulator of deacetylation for mitochondrial proteins, remains elusive. In this study, AML-12 cells were treated with palmitic acid to imitate the pathological changes of NASH in vitro and 8-week-old male C57BL/6J mice were fed with a high-fat (HF) diet or a methionine-choline-deficient (MCD) diet to build the widely accepted in vivo model of NASH. We found that lipid overload induced mitochondrial oxidative stress and stimulated the expression of CREBH and SIRT3. CREBH overexpression alleviated the mitochondrial oxidative stress. Moreover, CREBH promoted SIRT3 expression, which regulated the deacetylation of manganese superoxide dismutase (MnSOD) and inhibited NOD-Like Receptor Pyrin Domain Containing 3 (Nlrp3) inflammasome activation whereas suppression of SIRT3 damaged the protecting ability of CREBH in mitochondrial oxidative stress. CREBH knockout mice were highly susceptible to HF and MCD diet-induced NASH with more severe oxidative stress. Collectively, our results firstly provided the support that CREBH could serve as a protective factor in the progression of NASH by regulating the acetylation of MnSOD and the activation of Nlrp3 inflammasome through SIRT3. These results suggest that CREBH might be a valuable therapeutic candidate for NASH.
登录
查看更多内容
影响因子:
16
作者:
Hirschey MD;Shimazu T;Jing E;Grueter CA;Collins AM;Aouizerat B;Stančáková A;Goetzman E;Lam MM;Schwer B;Stevens RD;Muehlbauer MJ;Kakar S;Bass NM;Kuusisto J;Laakso M;Alt FW;Newgard CB;Farese RV Jr;Kahn CR;Verdin E
通讯作者:
Verdin E
影响因子:
5.4
作者:
Hao Y;Miao J;Liu W;Peng L;Chen Y;Zhong Q
通讯作者:
Zhong Q
影响因子:
4.6
作者:
Nakagawa Y;Satoh A;Tezuka H;Han SI;Takei K;Iwasaki H;Yatoh S;Yahagi N;Suzuki H;Iwasaki Y;Sone H;Matsuzaka T;Yamada N;Shimano H
通讯作者:
Shimano H
DOI:
10.1136/bmj.g4596
发表时间:
2014-07-29
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Sattar N;Forrest E;Preiss D
通讯作者:
Preiss D
影响因子:
6.1
作者:
Li Guixin;Zhang Junli;Jiang Qianqian;Liu Beibei;Xu Keshu
通讯作者:
Xu Keshu